Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement

LS Hiemcke-Jiwa; RJ Leguit; JH Radersma-van Loon; PE Westerweel; JJM Rood; Jeanette Doorduijn; MMH Huibers; MC Minnema

doi:10.1080/10428194.2017.1369074

Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement

LS Hiemcke-Jiwa
, RJ Leguit
, JH Radersma-van Loon
, PE Westerweel
, JJM Rood
, Jeanette Doorduijn
, MMH Huibers
, MC Minnema

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

23 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1256-1259
Number of pages	4
Journal	Leukemia & Lymphoma
Volume	59
Issue number	5
DOIs	https://doi.org/10.1080/10428194.2017.1369074
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1080/10428194.2017.1369074

REPUB_101714-OA.pdfFinal published version, 0.98 MB

http://hdl.handle.net/1765/101714

Cite this

@article{42c0c0eaa82747b89477487b3847813d,

title = "Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement",

author = "LS Hiemcke-Jiwa and RJ Leguit and \{Radersma-van Loon\}, JH and PE Westerweel and JJM Rood and Jeanette Doorduijn and MMH Huibers and MC Minnema",

year = "2018",

doi = "10.1080/10428194.2017.1369074",

language = "Undefined/Unknown",

volume = "59",

pages = "1256--1259",

journal = "Leukemia \& Lymphoma",

issn = "1042-8194",

publisher = "Taylor \& Francis Ltd (UK)",

number = "5",

}

TY - JOUR

T1 - Efficacy of ibrutinib in a patient with transformed lymphoplasmacytic lymphoma and central nervous system involvement

AU - Hiemcke-Jiwa, LS

AU - Leguit, RJ

AU - Radersma-van Loon, JH

AU - Westerweel, PE

AU - Rood, JJM

AU - Doorduijn, Jeanette

AU - Huibers, MMH

AU - Minnema, MC

PY - 2018

Y1 - 2018

U2 - 10.1080/10428194.2017.1369074

DO - 10.1080/10428194.2017.1369074

M3 - Article

C2 - 28849690

SN - 1042-8194

VL - 59

SP - 1256

EP - 1259

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

IS - 5

ER -